Successful second hematopoietic cell transplantation in severe congenital neutropenia
PEDIATRIC TRANSPLANTATION
Authors: Hashem, H.; Abu-Arja, R.; Auletta, J. J.; Rangarajan, H. G.; Varga, E.; Rose, M. J.; Bajwa, R. P. S.
Abstract
Allogeneic HCT is curative for SCN; however, a standard conditioning regimen or intensity has not been established. We describe a patient with SCN associated with c.1A>G (M1V) mutation in ELANE gene resulting in refractoriness to G-CSF, who received reduced-intensity HCT and developed secondary graft failure requiring a second myeloablative HCT. This case suggests that M1V mutation confers a poor G-CSF response and HCT using the best available donor is beneficial.
Quantitative and qualitative defects of neutrophilic granulocytes
MONATSSCHRIFT KINDERHEILKUNDE
Authors: Boztug, K.; Hauck, F. H.; Wintergerst, U.; Klein, C.
Abstract
Neutrophilic granulocytes constitute the body's first line of defence against bacterial and fungal pathogens and orchestrate the inflammatory response. The analysis of monogenic defects of neutrophilic granulocytes has yielded important insights into mechanisms of the innate immune system. Severe congenital neutropenia is defined by decreased numbers of absolute neutrophil counts and may be caused by mutations in ELANE/ELA2, HAX1, GFI1, WASP or G6PC3. Qualitative defects of neutrophilic granulocytes affect migration, activation and bacterial killing capacity which are manifested clinically as leukocyte adhesion deficiencies I-III (ITGB2, SLC35C1, FERMT3) and chronic granulomatous disease (CYBB, NCF1, NCF2, CYBA).